Department of Biochemistry and Immunology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
Department of Physiology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
Lipids. 2022 Nov;57(6):313-325. doi: 10.1002/lipd.12358. Epub 2022 Sep 13.
Although it is well established that glucocorticoids inactivate thermogenesis and promote lipid accumulation in interscapular brown adipose tissue (IBAT), the underlying mechanisms remain unknown. We found that dexamethasone treatment (1 mg/kg) for 7 days in rats decreased the IBAT thermogenic activity, evidenced by its lower responsiveness to noradrenaline injection associated with reduced content of mitochondrial proteins, respiratory chain protein complexes, noradrenaline, and the β -adrenergic receptor. In parallel, to understand better how dexamethasone increases IBAT lipid content, we also investigated the activity of the ATP citrate lyase (ACL), a key enzyme of de novo fatty acid synthesis, glucose-6-phosphate dehydrogenase (G6PD), a rate-limiting enzyme of the pentose phosphate pathway, and the three glycerol-3-P generating pathways: (1) glycolysis, estimated by 2-deoxyglucose uptake, (2) glyceroneogenesis, evaluated by phosphoenolpyruvate carboxykinase activity and pyruvate incorporation into triacylglycerol-glycerol, and (3) direct phosphorylation of glycerol, investigated by the content and activity of glycerokinase. Dexamethasone increased the mass and the lipid content of IBAT as well as plasma levels of glucose, insulin, non-esterified fatty acid, and glycerol. Furthermore, dexamethasone increased ACL and G6PD activities (79% and 48%, respectively). Despite promoting a decrease in the incorporation of U-[ C]-glycerol into triacylglycerol (54%), dexamethasone increased the content (55%) and activity (~41%) of glycerokinase without affecting glucose uptake or glyceroneogenesis. Our data suggest that glucocorticoid administration reduces IBAT thermogenesis through sympathetic inactivation and stimulates glycerokinase activity and content, contributing to increased generation of glycerol-3-P, which is mostly used to esterify fatty acid and increase triacylglycerol content promoting IBAT whitening.
虽然糖皮质激素可使棕色脂肪组织(BAT)产热失活并促进脂质积累已得到充分证实,但潜在机制尚不清楚。我们发现,在大鼠中用 1mg/kg 的地塞米松处理 7 天可降低 BAT 的产热活性,其表现为对去甲肾上腺素注射的反应性降低,同时伴随着线粒体蛋白、呼吸链蛋白复合物、去甲肾上腺素和β-肾上腺素能受体含量减少。与此平行,为了更好地理解地塞米松如何增加 BAT 的脂质含量,我们还研究了 ATP 柠檬酸裂解酶(ACL)的活性,ACL 是从头脂肪酸合成的关键酶;葡萄糖-6-磷酸脱氢酶(G6PD),戊糖磷酸途径的限速酶;以及甘油-3-P 的三个生成途径:(1)糖酵解,通过 2-脱氧葡萄糖摄取来估计;(2)甘油异生,通过磷酸烯醇丙酮酸羧激酶活性和丙酮酸掺入三酰甘油甘油来评估;(3)甘油的直接磷酸化,通过甘油激酶的含量和活性进行研究。地塞米松增加了 BAT 的质量和脂质含量,以及血浆中的葡萄糖、胰岛素、非酯化脂肪酸和甘油水平。此外,地塞米松还增加了 ACL 和 G6PD 的活性(分别增加了 79%和 48%)。尽管促进 U-[C]-甘油掺入三酰甘油的减少(54%),但地塞米松增加了甘油激酶的含量(55%)和活性(~41%),而不影响葡萄糖摄取或甘油异生。我们的数据表明,糖皮质激素给药通过交感神经失活减少 BAT 的产热,并刺激甘油激酶的活性和含量,有助于甘油-3-P 的产生增加,甘油-3-P 主要用于酯化脂肪酸和增加三酰甘油含量,促进 BAT 白化。